Read more about our studies' progress and milestones, new projects and clinical trial approvals
Find out why more than 50% of studies initiated in Russia are conducted by foreign sponsors with the US in the lead. Key experts from one of the major local CROs in Eastern Europe will share exclusive insights on 3 critical benefits of the region to advance your clinical strategy.
Within 45 minutes you will find out:
• Why it is faster and more cost-efficient to enroll patients in Russia;
• How to gain market authorization in several EEU countries having registered a drug only in one of them;
• What are the common hurdles CROs face when conducting studies in Russia and what you should do to overcome them;
• Real case studies that you can apply right away.
When: June 20
Time: 11 am PDT/ 2 pm EDT
* - Required fields